ICICI Securities Initiates Buy on Pine Labs, Sees 36% Upside to Rs 210
Brokerage cites diversified payments mix across subscription, affordability, issuer distribution and processing, plus international expansion. Forecasts 19% revenue CAGR, 37% Ebitda CAGR and 75% PAT CAGR through FY30, with PAT crossing Rs 1,000 crore.
What happened
ICICI Securities initiated Buy on Pine Labs with Rs 210 target (36% upside), citing diversified payments mix across subscription, affordability, issuer
Key facts
- Target Rs 210
- CMP Rs 154
- 36% upside
- Revenue CAGR 19% FY26-30E
- Ebitda CAGR 37%
- PAT CAGR 75%
- PAT >Rs 1,000 cr by FY30
Why this matters
International expansion and the four-pillar payments stack open inorganic angles in issuer distribution and affordability to accelerate the FY30 trajectory.